GEFITINIB

7849 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking GEFITINIB:

# Side effect Count
0 MALIGNANT NEOPLASM PROGRESSION 1468
1 DRUG RESISTANCE 1033
2 DIARRHOEA 826
3 RASH 585
4 DEATH 583
5 INTERSTITIAL LUNG DISEASE 401
6 DISEASE PROGRESSION 390
7 NAUSEA 348
8 DYSPNOEA 315
9 VOMITING 307
See all common reactions for GEFITINIB

GEFITINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MITOCHONDRIAL ASPARTATE AMINOTRANSFERASE INCREASED 9 0.8182
1 EGFR GENE MUTATION 74 0.3149
2 HER2 GENE AMPLIFICATION 3 0.3000
3 ACQUIRED GENE MUTATION 138 0.1700
4 SARCOMATOID CARCINOMA 4 0.1600
5 MALIGNANT TRANSFORMATION 44 0.1549
6 NON-SMALL CELL LUNG CANCER RECURRENT 12 0.1176
7 DRUG RESISTANCE 1033 0.0631
8 METASTASES TO MENINGES 81 0.0629
9 NEUROENDOCRINE TUMOUR OF THE LUNG 3 0.0556
See all enriched reactions for GEFITINIB